Patent ID: 8106093

Claim:
A pharmaceutical composition for treating a type II glycogen storage disease comprising: a pharmaceutically effective amount of an odd carbon fatty acid that comprises seven or less carbons that is substantially immediately bioavailable and is at least partially water-solubleand is sufficient to treat the glycogen storage disease, wherein the odd carbon fatty acid is adapted for a dosage of between 1 to 2 grams per kilogram body weight per day, wherein the odd carbon fatty acid comprises an acid value of 0.1 or less mg KOH/gr, a hydroxyl value of 2.8 or less mg KOH/gr; an emulsifier is selected from the group consisting of Imwitor 370, Imwitor 375, Imwitor 377, Imwitor 380 and Imwitor 829; one or more diluents; and a pharmaceutically acceptable carrier.